DELIVERING SUSTAINED GROWTH

We are diligently and sustainably achieving
excellence in all that we do

Aurobindo Overview

Founded in 1986 by Mr. P. V. Ramprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born of a vision. The company commenced operations in 1988-89 with a single unit manufacturing Semi-Synthetic Penicillin (SSP) at Pondicherry.

Aurobindo Pharma became a public company in 1992 and listed its shares on the Indian stock exchanges in 1995. In addition to being the market leader in Semi-Synthetic Penicillins, it has a presence in key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and anti-biotics, among others.

Strengths and Leadership

  • Large manufacturing facilities approved by leading regulatory bodies
  • Large diversified product portfolio
  • Large R&D facility in India for formulations and active ingredients

Learn More

Operational Excellence

  • Vertical integration
  • Proven regulatory expertise
  • Technology and know-how for specialty formulations

Learn More

24000 +
Employees World Wide
155 +
Markets we are present
27
State-of-the-art manufacturing and packaging facilities globally
40+ Billion
Dosage Forms